The potential of aerobic exercise training in mitigating cardiovascular side effects of cancer therapy

Future Cardiology

Volumn 11, Issue 4, 2015, Pages 407-411

  Berkman, Amy M ^a   Lakoski, Susan G ^b  

^a UNIVERSITY OF VERMONT   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

Cancer; Cardiorespiratory fitness; Cardiotoxicity; Cardiovascular disease; Exercise training

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOGENESIS INHIBITOR; ANTICOAGULANT AGENT; ANTIINFECTIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PROTEIN TYROSINE KINASE INHIBITOR;

AEROBIC EXERCISE; BODY WEIGHT DISORDER; BREAST CANCER; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVOR; CANCER THERAPY; CARDIORESPIRATORY FITNESS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR EFFECT; CARDIOVASCULAR RISK; COLORECTAL CANCER; ENDOMETRIUM CANCER; EXERCISE; FATIGUE; HEART DISEASE; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEMATOLOGIC MALIGNANCY; HUMAN; MOLECULARLY TARGETED THERAPY; MYOCARDIAL DISEASE; NOTE; PHYSICAL ACTIVITY; POSTTHROMBOSIS SYNDROME; PRIORITY JOURNAL; PROSTATE CANCER; RESISTANCE TRAINING; THROMBOSIS; VENOUS THROMBOEMBOLISM; WEIGHT GAIN; CARDIOTOXICITY; CARDIOVASCULAR DISEASES; NEOPLASMS;

CARDIOTOXICITY; CARDIOVASCULAR DISEASES; EXERCISE; HUMANS; NEOPLASMS;

EID: 84939418772     PISSN: 14796678     EISSN: 17448298     Source Type: Journal    
DOI: 10.2217/FCA.15.41     Document Type: Note

References (46)

1. Lenihan DJ, Cardinale DM. Late cardiac effects of cancer treatment. J. Clin. Oncol. 30(30), 3657-3664 (2012).
2. Mason C, Alfano CM, Smith AW et al. Long-term physical activity trends in breast cancer survivors. Cancer Epidemiol. Biomarkers Prev. 22(6), 1153-1161 (2013).
3. Jack S, West MA, Raw D et al. The effect of neoadjuvant chemotherapy on physical fitness and survival in patients undergoing oesophagogastric cancer surgery. Eur. J. Surg. Oncol. 40(10), 1313-1320 (2014).
4. Berkman AM, Lakoski SG. Treatment, behavioral, and psychosocial components of cardiovascular disease risk among survivors of childhood and young adult cancer. J. Am. Heart Assoc. 4(4), pii: e001891 (2015).
5. Harbeck N, Ewer MS, De Laurentiis M, Suter TM, Ewer SM. Cardiovascular complications of conventional and targeted adjuvant breast cancer therapy. Ann. Oncol. 22(6), 1250-1258 (2011).
6. Jones TH. Cardiovascular risk during androgen deprivation therapy for prostate cancer. BMJ 342, d3105 (2011).
7. Ky B, Vejpongsa P, Yeh ET, Force T, Moslehi JJ. Emerging paradigms in cardiomyopathies associated with cancer therapies. Circ. Res. 113(6), 754-764 (2013).
8. Force T, Kolaja KL. Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes. Nat. Rev. Drug Discov. 10(2), 111-126 (2011).
9. Peel AB, Thomas SM, Dittus K, Jones LW, Lakoski SG. Cardiorespiratory fitness in breast cancer patients: a call for normative values. J. Am. Heart Assoc. 3(1), e000432 (2014).
10. Meyerhardt JA, Giovannucci EL, Holmes MD et al. Physical activity and survival after colorectal cancer diagnosis. J. Clin. Oncol. 24(22), 3527-3534 (2006).
11. Jung HS, Myung SK, Kim BS, Seo HG. Metabolic syndrome in adult cancer survivors: a meta-analysis. Diabetes Res. Clin. Pract. 95(2), 275-282 (2012).
12. Fader AN, Arriba LN, Frasure HE, von Gruenigen VE. Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship. Gynecol. Oncol. 114(1), 121-127 (2009).
13. Seicean S, Seicean A, Plana JC, Budd GT, Marwick TH. Effect of statin therapy on the risk for incident heart failure in patients with breast cancer receiving anthracycline chemotherapy: an observational clinical cohort study. J. Am. Coll. Cardiol. 60(23), 2384-2390 (2012).
14. Vejpongsa P, Yeh ET. Prevention of anthracycline-induced cardiotoxicity: challenges and opportunities. J. Am. Coll. Cardiol. 64(9), 938-945 (2014).
15. Lyman GH, Bohlke K, Khorana AA et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: American society of clinical oncology clinical practice guideline update 2014. J. Clin. Oncol. 33(6), 654-656 (2015).
16. Clark AM, Hartling L, Vandermeer B, McAlister FA. Meta-analysis: secondary prevention programs for patients with coronary artery disease. Ann. Intern. Med. 143(9), 659-672 (2005).
17. Adamopoulos S, Schmid JP, Dendale P et al. Combined aerobic/inspiratory muscle training vs. aerobic training in patients with chronic heart failure: The Vent-HeFT trial: a European prospective multicentre randomized trial. Eur. J. Heart Fail. 16(5), 574-582 (2014).
18. Goldstein LB. Physical activity and the risk of stroke. Expert Rev. Neurother. 10(8), 1263-1265 (2010).
19. Faulkner J, Lambrick D, Woolley B, Stoner L, Wong LK, McGonigal G. Effects of early exercise engagement on vascular risk in patients with transient ischemic attack and nondisabling stroke. J. Stroke Cerebrovasc. Dis. 22(8), e388-e396 (2013).
20. Kahn SR, Shrier I, Shapiro S et al. Six-month exercise training program to treat postthrombotic syndrome: a randomized controlled two-centre trial. CMAJ 183(1), 37-44 (2011).
21. Lockard MM, Gopinathannair R, Paton CM, Phares DA, Hagberg JM. Exercise traininginduced changes in coagulation factors in older adults. Med. Sci. Sports Exerc. 39(4), 587-592 (2007).
22. Slentz CA, Duscha BD, Johnson JL et al. Effects of the amount of exercise on body weight, body composition, and measures of central obesity: STRRIDE-a randomized controlled study. Arch. Intern. Med. 164(1), 31-39 (2004).
23. Giannaki CD, Aphamis G, Sakkis P, Hadjicharalambous M. Eight weeks of a combination of high intensity interval training and conventional training reduce visceral adiposity and improve physical fitness: a group-based intervention. J. Sports Med. Phys. Fitness (2015) (Epub ahead of print).
24. Baster T, Baster-Brooks C. Exercise and hypertension. Aust. Fam. Physician 34(6), 419-424 (2005).
25. Blair SN, Kohl HW III, Paffenbarger RS Jr, Clark DG, Cooper KH, Gibbons LW. Physical fitness and all-cause mortality. A prospective study of healthy men and women. JAMA 262(17), 2395-2401 (1989).
26. Jones LW, Hornsby WE, Goetzinger A et al. Prognostic significance of functional capacity and exercise behavior in patients with metastatic non-small cell lung cancer. Lung Cancer 76(2), 248-252 (2012).
27. Jones LW, Courneya KS, Mackey JR et al. Cardiopulmonary function and age-related decline across the breast cancer survivorship continuum. J. Clin. Oncol. 30(20), 2530-2537 (2012).
28. Fong DY, Ho JW, Hui BP et al. Physical activity for cancer survivors: meta-analysis of randomised controlled trials. BMJ 344, e70 (2012).
29. Rogers LQ, Courneya KS, Anton PM et al. Effects of the BEAT Cancer physical activity behavior change intervention on physical activity, aerobic fitness, and quality of life in breast cancer survivors: a multicenter randomized controlled trial. Breast Cancer Res. Treat. 149(1), 109-119 (2015).
30. Midtgaard J, Christensen JF, Tolver A et al. Efficacy of multimodal exercise-based rehabilitation on physical activity, cardiorespiratory fitness, and patient-reported outcomes in cancer survivors: a randomized, controlled trial. Ann. Oncol. 24(9), 2267-2273 (2013).
31. May AM, Van Weert E, Korstjens I et al. Improved physical fitness of cancer survivors: a randomised controlled trial comparing physical training with physical and cognitive-behavioural training. Acta Oncol. 47(5), 825-834 (2008).
32. Smith WA, Ness KK, Joshi V, Hudson MM, Robison LL, Green DM. Exercise training in childhood cancer survivors with subclinical cardiomyopathy who were treated with anthracyclines. Pediatr. Blood Cancer doi: 10. 1002/pbc. 24850 (2013) (Epub ahead of print).
33. Lakoski SG, Barlow CE, Koelwyn GJ et al. The influence of adjuvant therapy on cardiorespiratory fitness in early-stage breast cancer seven years after diagnosis: the Cooper Center Longitudinal Study. Breast Cancer Res. Treat. 138(3), 909-916 (2013).
34. Tonorezos ES, Snell PG, Moskowitz CS et al. Reduced cardiorespiratory fitness in adult survivors of childhood acute lymphoblastic leukemia. Pediatr. Blood Cancer 60(8), 1358-1364 (2013).
35. Miller AM, Lopez-Mitnik G, Somarriba G et al. Exercise capacity in long-term survivors of pediatric cancer: an analysis from the Cardiac Risk Factors in Childhood Cancer Survivors Study. Pediatr. Blood Cancer 60(4), 663-668 (2013).
36. Courneya KS, Segal RJ, Mackey JR et al. Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial. J. Clin. Oncol. 25(28), 4396-4404 (2007).
37. Courneya KS, McKenzie DC, Mackey JR et al. Effects of exercise dose and type during breast cancer chemotherapy: multicenter randomized trial. J. Natl Cancer Inst. 105(23), 1821-1832 (2013).
38. Haykowsky MJ, Mackey JR, Thompson RB, Jones LW, Paterson DI. Adjuvant trastuzumab induces ventricular remodeling despite aerobic exercise training. Clin. Cancer Res. 15(15), 4963-4967 (2009).
39. Cormie P, Galvao DA, Spry N et al. Can supervised exercise prevent treatment toxicity in patients with prostate cancer initiating androgen-deprivation therapy: a randomised controlled trial. BJU Int. 115(2), 256-266 (2015).
40. Oechsle K, Aslan Z, Suesse Y, Jensen W, Bokemeyer C, de Wit M. Multimodal exercise training during myeloablative chemotherapy: a prospective randomized pilot trial. Support Care Cancer 22(1), 63-69 (2014).
41. Quist M, Adamsen L, Rorth M, Laursen JH, Christensen KB, Langer SW. The impact of a multidimensional exercise intervention on physical and functional capacity, anxiety, and depression in patients with advanced-stage lung cancer undergoing chemotherapy. Integr. Cancer Ther. 14(4), 341-349 (2015).
42. Sellar CM, Bell GJ, Haennel RG, Au HJ, Chua N, Courneya KS. Feasibility and efficacy of a 12-week supervised exercise intervention for colorectal cancer survivors. Appl. Physiol. Nutr. Metab. 39(6), 715-723 (2014).
43. Moonsammy SH, Guglietti CL, Mina DS et al. A pilot study of an exercise & cognitive behavioral therapy intervention for epithelial ovarian cancer patients. J. Ovarian Res. 6(1)21 (2013).
44. Lakoski S, Willis BL, Barlow CE et al. Midlife cardiorespiratory fitness, incident cancer, and survival after cancer in men: The Cooper Center Longitudinal Study. JAMA Oncol. 1(2), 231-237 (2015).
45. Singh F, Newton RU, Galvao DA, Spry N, Baker MK. A systematic review of presurgical exercise intervention studies with cancer patients. Surg. Oncol. 22(2), 92-104 (2013).
46. Jones LW, Eves ND, Mackey JR et al. Safety and feasibility of cardiopulmonary exercise testing in patients with advanced cancer. Lung Cancer 55(2), 225-232 (2007).